Immune Thrombocytopenic Purpura Cases Following COVID-19 Vaccination

Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021047. doi: 10.4084/MJHID.2021.047. eCollection 2021.

Annalisa Condorelli^{1

2}, Uros Markovic^{1

2

3}, Roberta Sciortino^{1

2}, Mary Ann Di Giorgio^{1

2}, Daniela Nicolosi¹, Gaetano Giuffrida¹

¹ Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy.
² Postgraduate School of Hematology, University of Catania, Italy.
³ Unità Operativa di Oncoematologia e BMT Unit, Istituto Oncologico del Mediteraneo, Viagrande, Italy.

No abstract available

Keywords: Adverse event; COVID 19; Immune thrombocytopenic purpura; Vaccination.